Source:http://linkedlifedata.com/resource/pubmed/id/15518124
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2004-11-2
|
pubmed:abstractText |
We reviewed the outcome of three methods employed for living-related renal transplantation (RTx) in our institution to assess triple immunosuppressive regimens. Between January 1989 and July 2003, a total of 35 living-related RTxs were performed at our institution. The immunosuppressive regimen given to 16 patients (group A) was cyclosporine (CsA), steroid and azathoprine (AZ) that given to 9 patients (group B) was tacrolimus (TAC), steroid and AZ and that given 9 patients (group C) was TAC, steroid and mycophenolate mofetil (MMF). Graft survival rate, serum creatinine, proteinuria, acute rejection, chronic allograft nephropathy (CAN), cytomegalovirus (CMV) infection and drug-induced nephropathy were investigated. There was no significant difference in graft survival rate among the three groups. Although serum creatinine levels (mg/dl) at 3 months post-transplant were 1.22+/-0.37 in group A, 1.43+/-0.14 in group B, 1.30+/-0.34 in group C, respectively (p<0.05; A vs. B), there was no significant difference at 1 year post-transplant. Frequency of proteinuria in groups A, B and C was 75.0, 50.0, 25.0%, respectively (p<0.05; A vs. C). The incidences of acute rejection and CAN within 1 year post-transplant were, respectively, 56.3% and 43.8% in group A, 37.5% and 37.5% in group B; and, 25.0% and 12.5% in group C (NS). The incidence of drug-induced nephrotoxicity was 12.5, 50.0% and 37.5% in groups A, B and C, respectively (p<0.05; A vs. B). The triple immunosuppressive therapy including calcineurin inhibitors, especially the regime of TAC, MMF, and steroids decreased the frequencies of proteinuria and rejections, which deteriorated the long-term outcome in living-related RTxs.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0018-1994
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
605-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15518124-Adult,
pubmed-meshheading:15518124-Azathioprine,
pubmed-meshheading:15518124-Cyclosporine,
pubmed-meshheading:15518124-Cytomegalovirus Infections,
pubmed-meshheading:15518124-Female,
pubmed-meshheading:15518124-Humans,
pubmed-meshheading:15518124-Immunosuppressive Agents,
pubmed-meshheading:15518124-Kidney Transplantation,
pubmed-meshheading:15518124-Living Donors,
pubmed-meshheading:15518124-Male,
pubmed-meshheading:15518124-Middle Aged,
pubmed-meshheading:15518124-Tacrolimus,
pubmed-meshheading:15518124-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
[Clinical results of immunosuppressive triple therapies in living-related renal transplantation--a single center experience].
|
pubmed:affiliation |
Department of Urology Graduate School of Medicine, Kyoto University.
|
pubmed:publicationType |
Journal Article,
English Abstract
|